
Overweight and obesity prevalence has increased worldwide. According to the Global Burden of Disease Obesity Collaborators, in 2015, 603.7 million adults were estimated to have obesity, with an overall prevalence of 12%.Adults with overweight or obesity were selected in a randomized, double-blind pilot study to complete 4 weeks (20 sessions) of fixed-dose tDCS (2 mA, 20 minutes) delivered over the rDLPFC and associated with a standard hypocaloric diet.Repetitive, active tDCS over the rDLPFC could be a promising noninvasive technique to improve glucose homeostasis in individuals with overweight or obesity on a low-calorie diet, highlighting the importance of investigating this intervention modality in individuals with type 2 diabetes mellitus.
Like
Save
Share